Arsenite, arsenate and vanadate affect human erythrocyte membrane.
Effects of arsenite, arsenate and vanadate on human erythrocyte membrane have been assessed according to their routes passing through the membrane, their binding modes to the membrane and their influences on membrane proteins and lipids. The uptake of arsenate (1.0 mM) by cells approached a limit with intracellular arsenic of about 0.2 mM in 5 h, and was strongly inhibited (approximately 95%) by 4,4'-diisothiocyano-2,2'-disulfonic stilbene (DIDS), indicating that arsenate, similar to vanadate, passed across the membrane through the anion exchange protein, band 3. Arsenite (1.0 mM) influx reached a maximum of about 0.4 mM in 30 min, and was not inhibited by DIDS. The transformed species of arsenite bound to the membrane from cytosol. In contrast, arsenate bound rapidly from the outside, followed by releasing and re-binding. The binding to the membrane via sulfhydryl was indicated by the decrease of the sulfhydryl level of membrane proteins. Polyacrylamide gel electrophoresis in sodium dodecyl sulfate (SDS-PAGE) analysis revealed that the proteins, bands 1-3, were among the targets of arsenite, arsenate and vanadate. Their binding to the membrane also induced changes in the fluidity of membrane lipids and in the negative charge density in the outer surface of the membrane.
Zhang
T L
TL
Department of Bioinorganic Chemistry and Inorganic Pharmaceutical Chemistry, Beijing Medical University, PR China.
Gao
Y X
YX
Lu
J F
JF
Wang
K
K
D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid / Q000494:pharmacology; D001149:Arsenates / Q000494:pharmacology*; D001151:Arsenic / Q000097:blood; D018053:Arsenites / Q000494:pharmacology*; D004910:Erythrocyte Membrane / Q000187:drug effects*; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism; D006461:Hemolysis; D006801:Humans; D007700:Kinetics; D008563:Membrane Lipids / Q000097:blood; D008565:Membrane Proteins / Q000097:blood / Q000187:drug effects; D017670:Sodium Compounds / Q000494:pharmacology*; D014638:Vanadates / Q000494:pharmacology*
D001149:Arsenates; D018053:Arsenites; D008563:Membrane Lipids; D008565:Membrane Proteins; D017670:Sodium Compounds; D014638:Vanadates; C017947:sodium arsenite; C009277:sodium arsenate; D001151:Arsenic; D017878:4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid